Bender James G. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Jul 31, 2012
Insider Transaction Report
Form 4
Bender James G.
VP, Product Development & Mfg.
Transactions
- Award
Stock Option (right to buy)
2012-06-11+75,000→ 75,000 totalExercise: $3.42Exp: 2019-01-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Option granted on June 11, 2012 to vest in equal monthly installments over a four-year period from February 1, 2012, which was the date of renewal of reporting person's employment agreement.